Are all IV thrombolysis exclusion criteria necessary?: Being SMART about evidence-based medicine

Neurology

Volumn 76, Issue 21, 2011, Pages 1780-1781

  Tong, David ^a  

^a CALIFORNIA PACIFIC MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALTEPLASE;

BLOOD CLOT LYSIS; BRAIN HEMORRHAGE; CEREBROVASCULAR DISEASE; CLINICAL DECISION MAKING; CLINICAL PROTOCOL; DISEASE SEVERITY; EDITORIAL; EVIDENCE BASED MEDICINE; HEART INFARCTION; HUMAN; PRACTICE GUIDELINE; PRIORITY JOURNAL; STROKE PATIENT; TREATMENT CONTRAINDICATION; TREATMENT OUTCOME;

EID: 79958128567     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/WNL.0b013e31821ccd60     Document Type: Editorial

References (11)

1. Majersik JJ, Smith MA, Zahuranec DB, Sanchez BN, Morgenstern LB. Population-based analysis of the impact of expanding the time window for acute stroke treatment. Stroke 2007;38:3213-3217. (Pubitemid 350175739)
2. Schumacher HC, Bateman BT, Boden-Albala B, et al. Use of thrombolysis in acute ischemic stroke: analysis of the nationwide inpatient sample 1999 to 2004. Ann Emerg Med 2007;50:99-107. (Pubitemid 47079072)
3. Moskowitz MA. Brain protection: maybe yes, maybe no. Stroke 2010;41:S85-S86.
4. Aleu A, Mellado P, Lichy C, Kohrmann M, Schellinger PD. Hemorrhagic complications after off-label thrombolysis for ischemic stroke. Stroke 2007;38:417-422. (Pubitemid 46184319)
5. De Keyser J, Gdovinova Z, Uyttenboogaart M, Vroomen PC, Luijckx GJ. Intravenous alteplase for stroke: beyond the guidelines and in particular clinical situations. Stroke 2007;38:2612-2618. (Pubitemid 47329647)
6. Mishra NK, Ahmed N, Andersen G, et al. Thrombolysis in very elderly people: controlled comparison of sits international stroke thrombolysis registry and virtual international stroke trials archive. BMJ 2010;341:c6046.
7. Mishra NK, Davis SM, Kaste M, Lees KR. Comparison of outcomes following thrombolytic therapy among patients with prior stroke and diabetes in the virtual international stroke trials archive (vista). Diabetes Care 2010;33:2531-2537.
8. Rubiera M, Ribo M, Santamarina E, et al. Is it time to reassess the sits-most criteria for thrombolysis? A comparison of patients with and without sits-most exclusion criteria. Stroke 2009;40:2568-2571.
9. Tong DC, Barazangi N, Rose J, et al. Increasing IV rt-PA use using modern eligibility criteria: the Simplified Management of Acute Stroke using Revised Treatment (SMART) criteria study: feasibility, safety and efficacy. Presented at the annual meeting of the American Academy of Neurology; April 10-17, 2010; Toronto, Ontario, Canada.
10. Generalized efficacy of t-PA for acute stroke: subgroup analysis of the NINDS t-Pa Stroke Trial. Stroke 1997;28: 2119-2125.
11. De Silva DA, Manzano JJF, Chang HM, Wong MC. Reconsidering recent myocardial infarction as a contraindication for IV stroke thrombolysis. Neurology 2011;76: 1838-1840.